Free Daily Podcast Summary
Beyond Biotech - the podcast from Labiotech: Daily Summaries Delivered
by Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry. The host is Dylan Kissane.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 3 weeks ago28 min
GLP-1 muscle loss: the next battleground in obesity treatment (Part 2 of 3)
Welcome to a special three-part series called 'The Metabolic Moment'. In just a few years, GLP-1 drugs have become a phenomenon. They’ve transformed how we treat diabetes and obesity, created one of the biggest markets in pharma, and sparked a cultural conversation that reaches far beyond the clinic. Now that market is shifting. Cheaper alternatives are coming, new mechanisms are entering trials, and some companies are aiming for something closer to a cure. So what happens next for patients, ...
- 4 weeks ago36 min
The next big shake-up in the GLP-1 market? (Part 1 of 3)
Welcome to a special three-part series called 'The Metabolic Moment'. In just a few years, GLP-1 drugs have become a phenomenon. They’ve transformed how we treat diabetes and obesity, created one of the biggest markets in pharma, and sparked a cultural conversation that reaches far beyond the clinic. Now that market is shifting. Cheaper alternatives are coming, new mechanisms are entering trials, and some companies are aiming for something closer to a cure. So what happens next for patients, ...
- Oct 9, 202634 min
Saudi Arabia's biotech momentum: inside RGMBS 2026
Saudi Arabia has spent the last four years building one of the most ambitious biotech gatherings in the region: the Riyadh Global Medical Biotechnology Summit. This September, the fourth edition brought together delegations from more than 57 countries and over 200 speakers, closing with more than 40 agreements and initiatives worth over SAR5 billion. From gene editing and genomics to AI-driven drug discovery and biomanufacturing, the Summit is positioning itself as a serious node in the globa...
- Oct 2, 202636 min
How Flagship's Valo is reshaping AI drug discovery with human data
AI has been one of the biggest buzzwords in biotech for years now — but for all the technological progress, actual R&D productivity gains have been hard to find, and the cost of developing a new drug keeps climbing. My guest today believes that's because AI alone was never going to be the answer. Valo, a biotech founded by Flagship Pioneering, is betting on a different approach: combining AI, predictive chemistry, and — crucially — real-world human data from the very start of drug discov...
- Sep 25, 202644 min
Theialife’s race to bring a childhood myopia treatment to market
By 2050, nearly half the world's population is expected to be myopic, with around a billion people projected to progress to high myopia — a leading cause of irreversible vision loss later in life. Children face a narrow window in which to intervene, while the eye is still growing, before those structural changes become permanent. Yet despite the scale of the problem, there is still no FDA-approved drug that slows myopia progression in children, a gap underscored just last month when the FDA d...
- Sep 18, 202640 min
The best biotech conversations you missed this summer
Summer is a busy time for everyone, guests and listeners alike, so today we're taking stock. This is our Summer Recap — a clips episode pulling together the best moments from conversations you might have missed over the past few months. We'll hear from Randy Teel of Arvinas and Per Lundin of Evox on two very different ways of getting drugs to the brain, and Laurent Lévy of Nanobiotix on outsmarting the liver altogether. We'll meet the founders behind these companies, including Andy Parker of ...
- Sep 11, 202630 min
Rewriting the rules of genetic medicine with tRNA therapeutics
Most genetic medicines are built to treat one gene, one mutation, one disease at a time. That's true even for the newest modalities — gene therapy, gene editing, mRNA — each still has to be engineered disease by disease. Alltrna is testing a different idea: that the real target isn't the gene, but the process of translation itself, where genetic instructions become protein. The company's lead approach focuses on nonsense mutations, a shared error responsible for roughly a tenth of all genetic...
- Sep 4, 202631 min
How Evox Therapeutics is targeting CNS diseases with exosomes
Gene therapy has largely stayed out of the brain, and the blood-brain barrier has been the reason why — it protects the brain from harm, but it also blocks most advanced medicines from ever reaching it. That's now beginning to change. The recent FDA approval of a brain-penetrant enzyme therapy for Hunter syndrome showed that biologics can cross that barrier and work. The next question is whether gene editing can do the same. My guest today is Dr. Per Lundin, Co-Founder and CEO of Evox Therape...
Get Beyond Biotech - the podcast from Labiotech summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
LONGEVITY with Nathalie Niddam
Explores science-backed strategies for extending healthspan through nutrition, biohacking, peptides, and emerging longevity research.
Biohack-it
A weekly exploration of biohacking, holistic health, and science-driven strategies for optimizing physical and mental well-being.
TBPN
Daily tech talk show featuring interviews with prominent tech leaders and condensed highlights of key discussions.
A Shot in the Arm Podcast
Ben Plumley
Solutions with Henry Blodget
Henry Blodget interviews experts in business, tech, and politics about practical solutions for building a better future.
Galaxy Balance
Explores the intersection of biology, technology, and consciousness through deep conversations with innovators shaping humanity’s future.
The Best One Yet
A daily 20-minute podcast breaking down the three key business stories with sharp, accessible takes.
Babbage from The Economist
A weekly exploration of science and technology, from AI and genetics to space travel, featuring interviews with leading researchers.
The VPZD Show
Two physicians discuss healthcare, medicine, and policy from a contrarian, middle-ground perspective.
Sam Miller Science
Sam Miller
The Health Continuum
High-performing professionals learn science-based health strategies to sustain energy, focus, and resilience in demanding careers.
What Next: TBD | Tech, power, and the future
A weekly look at how technology and power are shaping the future, from algorithms to artificial intelligence and beyond.
About Beyond Biotech - the podcast from Labiotech
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry. The host is Dylan Kissane.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Beyond Biotech - the podcast from Labiotech in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Beyond Biotech - the podcast from Labiotech daily summary?
It's a free AI-powered email that summarizes new episodes of Beyond Biotech - the podcast from Labiotech as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Beyond Biotech - the podcast from Labiotech podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Beyond Biotech - the podcast from Labiotech product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Labiotech.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does Beyond Biotech - the podcast from Labiotech release new episodes?
Beyond Biotech - the podcast from Labiotech publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does Beyond Biotech - the podcast from Labiotech cover?
Beyond Biotech - the podcast from Labiotech covers topics including News. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Beyond Biotech - the podcast from Labiotech summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.